News and Trends 1 Sep 2017
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer's disease.…
Allergan
- Latest Posts
News and Trends 20 Jun 2017
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive Phase III results for AMD.…
News and Trends 18 Apr 2017
Two Big Pharma Players Team up to Take Over the NASH Space
Allergan has entered a clinical collaboration with Novartis to run a Phase IIb study combining its immunomodulator and Novartis' FXR agonist…
News and Trends 15 Mar 2017
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
Allergan has signed a deal with Editas Medicine to access its CRISPR technology and license up to five of its…
ADVERTISEMENT
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 7 Apr 2016
Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech
Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer's, to Allergan for up to…
News and Trends 25 Nov 2015
Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!
Novartis is hitting back in the Biosimilar battleground: now Neulasta, the white blood cell booster for Cancer, is the latest…
News and Trends 23 Nov 2015
Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!
The Rumor became more and more tangleon what is now the biggest Pharma deal ever. The Rumor was pumped up…
News and Trends 29 Oct 2015
To beat J&J, Pfizer attempts a New Merger…Guess who’s the Target this Time?!
Mergers & acquisitions (or M&A in short) have ruled the world of Pharma for a while and the company which seems…
News and Trends 25 Sep 2015
Roche’s patent halts an Amgen biosimilar debut
Amgen has had great success with its Avastin biosimilar, used as an inhibitor of angiogenesis in tumor growth. However, despite…
News and Trends 26 Aug 2015
Oh dear, Allergan is doing its 4th product recall in 2015 …
Allergan is fighting with manufacturing problems - again! The packaging of some eye treating products were defective and contaminated the…
News and Trends 28 Jul 2015
Allergan Continues its Serial Acquisitions to be a Giant Drugmaker
With Allergan's absorption by Actavis last year, we ask ourselves, will the newly formed company enter the World's Top Ten drugmaker companies…
News and Trends 24 Nov 2014
Will New Actavis-Allergan Entity Lead to Be in the World Top 10 Drugmakers Companies?
The US pharmaceutical company Allergan, known for their Botox, agreed an Actavis bid of 53 billion euros, they permanently passed…
